International Journal of Obstetrics and Gynecology

Objective: To analyze the effect of progesterone and low molecular weight heparin sodium in the treatment of patients with recurrent abortion. Methods: Inquiry according to the comparative observation of the treatment, 80 patients with total into, belong to our hospital from March 2019 to March 2022 treated patients, according to the grouping double-blind way is divided into two groups, namely the control group (40 cases, carries on the routine therapy) and observation group (40 cases, according to the progesterone, low molecular heparin therapy) together. Compare the patients recovery. Results: The levels of D-dimer, fibrinogen and fibrin degradation products of the two groups during the treatment showed no significant difference between the two groups before treatment (P>0.05). After treatment, the observation group was significantly better than the control group (P<0.05). The levels of chorionic gonadotropin, progesterone and estradiol in the two groups were statistically analyzed, and there was no difference between the two groups before treatment (P>0.05). After treatment, the levels of each hormone in the observation group were better than those in the control group (P<0.05). The improvement time of bleeding symptoms, abdominal pain symptoms and lumbar acid swelling symptoms during treatment was statistically analyzed, and the time of observation group was shorter than that of control group (P<0.05). Compared with the adverse reactions during treatment, the incidence of adverse reactions in the observation group was lower than that in the control group (P<0.05). Conclusion: The treatment of progesterone and low molecular weight heparin sodium in the process of fetal preservation therapy for patients with recurrent abortion can quickly relieve the corresponding symptoms, improve the hormone level and coagulation function of patients, and help to improve the pregnancy outcome.

progesterone; Low molecular weight heparin sodium; Recurrent abortion